(1-18-19) Dr. E. Fuller Torrey is criticizing the National Institute of Mental Health (NIMH) for failing to fund new drug trials for medicines that could help treat schizophrenia.
Dr. Torrey is one of the nation’s leading experts on schizophrenia and is the author of the groundbreaking 1983 book, Surviving Schizophrenia, widely considered the standard reference book about the illness.
In an article published this week in the Journal of Clinical Psychiatry, Torrey was joined by two other physicians, in challenging a NIMH policy that has resulted in the government founding only two new trials for schizophrenia drugs between 2015 to 2017.
NIMH was created in 1946 to find better drugs for treating mental illnesses.
“It is completely unacceptable for NIMH to virtually abandon the search for new drugs for schizophrenia,” Dr. Torrey wrote in an email, “especially at this time when NIMH has received major increases in funding from Congress over the past two years. All of us who want better drug treatments for individuals with schizophrenia should let Dr. Joshua Gordon (head of NIMH) know how important such trials are, and that we are looking over his shoulder to make sure they are done.”